Primary hyperoxaluria type 2 (PH2) is a rare autosomal recessive disease characterized by excessive synthesis and excretion of L-glycerate and oxalate. The enzyme D-glycerate dehydrogenase (D-GDH; EC 1.1.1.29) has been found to be deficient in peripheral blood leucocytes from PH2 patients (Williams & Smith, 1968; Chalmers et al., 1984) . The mechanism of the hyper-L-glyceric aciduria in PH2 is clear, whereas there are a number of different hypotheses which attempt to explain the hyperoxaluria (Williams & Smith, 1968 , 1971 Liao & Richardson, 1978; Fry & Richardson, 1979; Chalmers & Lawson, 1982) . D-GDH also possesses glyoxylate reductase (GR; EC 1.1.1.26/79) activity (Willis & Sallach, 1962; Dawkins & Dickens, 1965) . Therefore, in the present study, we have measured the activities of both D-GDH and GR in the liver from a patient with PH2, and compared the results with control livers and livers from patients with primary hyperoxaluria type 1 (PH1).
For the determination of total enzyme activities, liver homogenates (10-1 5% wet weight in 0.154 M-KCI, 0.01 Mmercaptoethanol and 0.1 M-MnC 1 ?) were dialysed against 0.05 M-sodium acetate buffer, pH 6.0, containing 0.01 Mmercaptoethanol, and then centrifuged at 2000 g for 30 min to remove any insoluble material. The activity of D-GDH was assayed in both directions using either o-glycerate or hydroxypyruvate as substrates, while GR and lactate dehydrogenase (LDH; E C 1.1.1.27) were assayed using glyoxylate and pyruvate, respectively. The standard assay conditions, used to measure the reduction reactions, were modified from Williams & Smith (1968) (1972) as follows. Sample protein (0.25-0.5 mg) was added to make a total volume of 3 ml containing 1 0 pmol of hydroxypyruvate, glyoxylate or pyruvate and 1 .5 pmol of NADPH or NADH (see Table 1 ) in 0.01 M-sodium phosphate buffer pH 7.0. The decrease in absorbance at 340 nm was determined at 30°C. The oxidation reaction of D-GDH was performed similarly, but because of the unfavourable kinetics of the reaction in this direction (Sugimoto et ul., 1972) , the reaction solution contained 100 pmol of Dglycerate, 1.5 pmol of NADP or NAD (see Table 1 ). 600 pmol of hydrazine sulphate, pH '3.0, in 0.25 M-Tris/HCI buffer, pH 9.0. Alanine-glyoxylate aminotransferase ( AGT, EC 2.6.1.44) was assayed by the method of Rowsell et al. (1972) and protcin by the method of Lowry et al. ( 195 1 ) . For the subcellular fractionation experiments, fresh liver samples were homogenized and subjected to isopycnic sucrose gradient centrifugation as described previously (Danpure et al., 1986) .
Using NADP(H), the activities of D-GDH, using both Dglycerate and hydroxypyruvate as substrates, and GR were markedly reduced in the PH2 liver, compared with the control livers ( Table 1 ). The PH1 livers had normal activities. On the other hand, the activity of AGT (the deficient enzyme in PH1) was greatly decreased in the PH1 livers, but unaltered in the PH2 liver. All the redox reactions were normal, or possibly elevated, in the PH2 liver when NAD(H) was used (Table 1) due to the dominating effect of LDH, which can use hydroxypyruvate (Anderson et al., 1964; Dawkins & Dickens, 1965; Feld & Sallach, 1975) and glyoxylate (Sawaki & Yamada, 1966; Banner & Rosalki, 1967; Feld & Sallach, 1975) as substrates as well as pyruvate. Sucrose gradient subcellular fractionation of a control liver showed that the activities of D-GDH (in both directions) and GR (see Suzuki et al., 1973) were mainly ( > 9O0/0) cytosolic, with a small proportion in the mitochondria.
These data on PH2 liver confirm the previous findings in leucocytes (Williams & Smith, 1968; Chalmers et ul., 1984) . Glyoxylate is the most important immediate precursor of oxalate. Therefore impairment of its reduction to glycolate, due to cytoplasmic GR deficiency, could result in excessive (Danpure & Jennings, 1986) , allowing peroxisomal glyoxylate to pass into the cytosol to be oxidized to oxalate by LDH.
Primary hyperoxaluria type 1 (PH 1 ) is an autosomal recessive inborn error of glyoxylate metabolism caused by a deficiency of the hepatic peroxisomal enzyme alanine-glyoxylate aminotransferase (ACT; EC 2.6.1.44) (Danpure & Jennings, 1986) . Only a minority of these ACT-deficient patients (three out of 12) possess detectable amounts of immunoreactive AGT protein ( C R M + ) (Wise et al., 1987) . The aim of the present study is to use immunocytochemical methods to investigate the intracellular distribution of AGT protein in normal human liver and in the livers of PHI patients (both CRM + and CRM -).
Fresh liver biopsies, from three controls, a PHI heterozygote and four PH 1 homozygotes, were fixed in 1% or 3"/0 glutaraldehyde and embedded in Lowicryl K4M (Carlemalm ct ul., 1982) for post-embedding immunocytochemistry with the protein A-gold technique (Roth, 1982) . Anti-human ACT antiserum was raised in rabbits as described previously (Wise et al.. 1987) . The immunogenicity of the AGT protein was unaffected by glutaraldehyde fixation as judged by dotblotting (Moeremans el ul., 1984) .
In all the CRM + liver samples (i.e. normals, heterozygote and CRM + homozygote), the immunoreactive AGT protein was entirely confined to the peroxisomes (Fig. 1) . Liver from CRM -patients showed no labelling of the peroxisomes, any other organelles or cytosol. Subcellular fractionation of human liver homogenates has demonstrated the peroxisomal localization of ACT enzyme activity (Noguchi & Takada, 1979) and immunoreactive ACT protein (Wise et al., 1987) . In the PH 1 heterozygote, who possessed approximately 50% ACT enzyme activity (C. J. Danpure & P. R. Jennings, unpublished work) , the density of labelling for immunoreactive ACT protein was similarly reduced compared with the Abbreviations used: PHI, primary hyperoxaluria type I ; ACT, alanine-glyoxylate aminotransferase (EC 2.6.1.44); CRM + , CRM -, immunoreactive ACT present or absent, respectively. control livers. In the CRM+ PHI patient, who had a complete deficiency of AGT enzyme activity, the density and distribution of gold labelling was similar to the controls. The increased immunoreactive ACT protein found in liver homogenates from this patient by immunoblotting (P. J. Wise & C. J. Danpure, unpublished work) may be due to peroxisoma1 proliferation.
AGT immunoreactive protein is clearly randomly distributed across the peroxisomal matrix, with no evidence of VOl. 16
